FRONTLINE Editor-in-Chief and Executive Producer Raney Aronson-Rath sits down with journalists and filmmakers for probing conversations about the investigative journalism that drives each FRONTLINE documentary and the stories that shape our time. Produced at FRONTLINE’s headquarters at GBH and powered by PRX. The FRONTLINE Dispatch is made possible by the Abrams Foundation Journalism Initiative.
…
continue reading
Content provided by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Full Conversation- America's Drug Price Nightmare: Public Production Can Save Lives
MP3•Episode home
Manage episode 494984008 series 1535187
Content provided by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Pharmaceutical prices in the US are astronomically high and many vulnerable people can’t afford the drugs they need. Public ownership of drug manufacturing can break the private monopolies and save lives, but it’s going to take a lot of public pressure to make change. Today, we look at the progress that’s being made to tackle America’s killer drug price problem at the state, national and global level. The Biden administration’s agreement with manufacturer Eli Lilly to cap insulin prices at $35/dose is a step, but what would really make a difference would be to get private profit and monopoly patents out of the health business altogether. In the US, California is taking the lead. Advocates Dana Brown, Luis Gil Abinader and Kevin Wren join Laura to bring us an update – and in her closing, Laura shares some news about the impact of our investigative series from North Carolina. Guests: •Dana Brown: Director, Health & Economy, The Democracy Collaborative •Luis Gil Abinader: Legal Scholar; Fellow, Georgetown University Law O'Neill Institute; Board Member, Universities Allied for Essential Medicines (UAEM) •Kevin Wren: Queer Activist & Patient Advocate Chapter Leader, California #insulin4all; T1 International; Queer Activist & Patient Advocate, MA Evans School of Public Policy & Governance, University of Washington
…
continue reading
259 episodes
MP3•Episode home
Manage episode 494984008 series 1535187
Content provided by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by F-Word + Audio Extras: Laura Flanders & Friends and Laura Flanders or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Pharmaceutical prices in the US are astronomically high and many vulnerable people can’t afford the drugs they need. Public ownership of drug manufacturing can break the private monopolies and save lives, but it’s going to take a lot of public pressure to make change. Today, we look at the progress that’s being made to tackle America’s killer drug price problem at the state, national and global level. The Biden administration’s agreement with manufacturer Eli Lilly to cap insulin prices at $35/dose is a step, but what would really make a difference would be to get private profit and monopoly patents out of the health business altogether. In the US, California is taking the lead. Advocates Dana Brown, Luis Gil Abinader and Kevin Wren join Laura to bring us an update – and in her closing, Laura shares some news about the impact of our investigative series from North Carolina. Guests: •Dana Brown: Director, Health & Economy, The Democracy Collaborative •Luis Gil Abinader: Legal Scholar; Fellow, Georgetown University Law O'Neill Institute; Board Member, Universities Allied for Essential Medicines (UAEM) •Kevin Wren: Queer Activist & Patient Advocate Chapter Leader, California #insulin4all; T1 International; Queer Activist & Patient Advocate, MA Evans School of Public Policy & Governance, University of Washington
…
continue reading
259 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.